vimarsana.com

Page 7 - கோட்டை நினைவகம் ஆராய்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Green fungus now a major threat after Covid recovery

Green fungus now a major threat after Covid recovery SECTIONS Share Synopsis While mucormycosis affects sinuses, aspergillosis affects the lungs of a patient. It is not as severe a disease as mucormycosis, which requires debulking surgeries (surgical removal of affected tissue including in eye). AP After mucormycosis or black fungus, another fungal infection, aspergillosis or green fungus is emerging as a post-Covid complication in patients across the country. Hospitals across states are increasingly reporting aspergillosis in patients who have recently recovered from long Covid-19 infection and have low immunity and comorbidities like diabetes. “Patients who have recovered from long Covid are reporting back with breathlessness and high-grade fever, which is not going even with regular antibiotic treatment,” said Vivek Nangia, principal director (pulmonology) at Max Hospital Saket. “It is usually occurring in patients with diabetes and low immunity.”

Fortis Memorial Research Institute in Gurugram begins Sputnik V vaccine trial run for general public

Highlights Fortis Memorial Research Institute in Gurugram has begun its pilot soft launch of the Russian COVID vaccine Sputnik V. The Institute has procured the vaccine stock directly from Dr Reddy s Laboratories. It has started the trial run for the general public and vaccinated 471 people. New Delhi: To add pace to the national COVID-19 vaccination programme, the Fortis Memorial Research Institute in Gurugram has begun its pilot soft launch of the Russian COVID-19 vaccine Sputnik V, the ANI reported on Sunday (June 27, 2021). The Institute has procured the vaccine stock directly from Dr Reddy s Laboratories. The response to the pilot soft launch of the Sputnik V has been overwhelming at Fortis Memorial Research Institute, Gurugram. The vaccination launch was successfully driven in collaboration with Dr Reddy s Laboratories, said a statement issued by the Fortis Memorial Research Institute.

sputnik v vaccine: Gurugram s Fortis Memorial Research Institute starts Sputnik V trial run for general public

Synopsis The institute has started the trial run for the general public and vaccinated 471 people. In April, the vaccine received emergency use authorisation in India, making it the third vaccine to be made available in the country against COVID-19. Reuters The Fortis Memorial Research Institute in Gurugram has started its pilot soft launch of the Russian COVID-19 vaccine Sputnik V and the hospital has procured the vaccine stock directly from Dr Reddy s Laboratories. The response to the pilot soft launch of the Sputnik V has been overwhelming at Fortis Memorial Research Institute, Gurugram. The vaccination launch was successfully driven in collaboration with Dr Reddy s Laboratories, said a statement issued by the Fortis Memorial Research Institute.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.